Elevance Health Inc. stock outperforms competitors on strong trading day
Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.
Positive Outlook for Elevance Health Amid Strategic Positioning and Revenue Growth
Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...
Elevance Health: Attractive Valuation and Stable Growth Prospects Drive Buy Rating
Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...
Barclays Issues Positive Forecast for Elevance Health (NYSE:ELV) Stock Price
Elevance Health (NYSE:ELV – Free Report) had its price target upped by Barclays from $501.00 to $512.00 in a report published on Friday,Benzinga reports. The firm currently has an overweight rating on ...
Health Care Up as Traders Rotate Out of AI Issues -- Health Care Roundup
The SPDR Health Care Sector exchange-traded fund, which tracks the health-care industry group of the broad S&P 500, rose by roughly 2%, and is now up about 7% for the year to date.
CNN11h
After-hours
We read every day so you don't have to. Sign up for CNN Business' nightly newsletter for the top stories you need to know.
Canada15h
Public Health Agency of Canada
The Public Health Agency of Canada is part of the federal health portfolio. Our activities focus on protecting against threats to public health, preventing and reducing diseases and injury, and ...